3rd Quarter - Report
KOUNTOUPES DENHAM CARR & REID, LLC for GLENMARK PHARMACEUTICALS, INC., USA
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to H. R. 1628, The American Health Care Act and the Senate version, the Better Care Reconciliation Act, H. R. 2430, The FDA Reauthorization Act of 2017, and S. 934, the FDA Reauthorization Act of 2017.
Foreign entity interest: Glenmark
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
| MARY R "RANDI" REID | — |
| ROSE SULLIVAN (LISTED IN ERROR) | — |
Medicare/Medicaid MMM
Issues related to Medicaid CPI Penalty.
Foreign entity interest: Glenmark
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
Pharmacy PHA
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals.
Foreign entity interest: Glenmark
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
| MARY R "RANDI" REID | — |
| ROSE SULLIVAN (LISTED IN ERROR) | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.